Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Og Rimon Consulting Ltd. (RMON)
Market Closed
12 Jun, 15:25
TASE
All
(1)
IL
(1)
TASE
Primary
13,230.
00
ILA
+250
+1.926%
ILA
416.62B
Market Cap
16.59
P/E Ratio
365.37%
Div Yield
71,278
Volume
0
Eps
12,980
ILA
Previous Close
Watching
Watch
Add Transaction
Day Range
12,570
13,390
Year Range
4,135
13,550
Want to track
RMON
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Statistics
Historical Data
Og Rimon Consulting Ltd. (RMON) Statistics
Valuation metrics
Market Cap
416.62B
Enterprise value
5.17B
Trailing P/E (ttm)
69.19
Forward P/E
-
PEG ratio
6.12
Price/Sales (ttm)
2.91
Price/Book (mrq)
7.63
Enterprise Value/Revenue
3.21
Enterprise Value/EBITDA
21.82
Overview
Shares outstanding
36.11M
Float
14.39M
Shares short
-
% Held by insiders
0.6%
% Held by institutions
0.36%
Average volume (10 days)
17.98K
Average volume (90 days)
56.02K
Price summary
52-Week low
4,135
52-Week high
13,550
Beta
1.04
50-Day moving average
11,871.67
200-Day moving average
10,741.26
Financials
Fiscal year
Fiscal year ends
31 Dec 2024
Most recent quarter (mrq)
30 Sep 2025
Profitability
Profit margin
0.04%
Operating margin
0.09%
Operational effectiveness
Return on assets
0.03%
Return on equity
0.11%
Income Statement
Revenue (ttm)
910.79M
Revenue per share (ttm)
44.49
Quarterly revenue growth (yoy)
0.88%
Gross profit (ttm)
144.82M
EBITDA
213.3M
Net income to common (ttm)
60.02M
Diluted EPS (ttm)
1.87
Quarterly earnings growth (yoy)
0.19%
Balance Sheet
Total cash (mrq)
-
Total cash per share (mrq)
9.71
Total debt (mrq)
762.78M
Total Debt/Equity (mrq)
1.36
Current ratio (mrq)
1.2%
Book value per share (mrq)
18.83
Cash Flow
Cash flow statement
-27.86M
Levered free cash flow (LFCF)
60.02M